Intelligence / Healthtech / New Clinical Trials / IR INNOVATE RESEARCH PRIVATE LIMITED
IR INNOVATE RESEARCH PRIVATE LIMITED
5 Nov 2026: Trial registered · Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 5 Nov 2026
- Title
- Safety, Tolerability, and Clinical Effectiveness of Adapalene/Clindamycin Phosphate Gel (Klenzit®-C) in Vietnamese Patients With Mild to Moderate Acne Vulgaris
- Conditions
- Acne
- Phase
- Phase 4
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- Vietnam
- Country
- Vietnam
- Reference
- NCT07918001
- Location
- Vietnam
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Find the decision makers at IR INNOVATE RESEARCH PRIVATE LIMITED
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Vietnam
New Clinical Trials
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.